Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | FBP1 | P09467 | 9/20 | 0.51 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29473347 | 1.00 | ALDH1A1 (0.57) | ALDH1A1TSHRHSD17B10TDP1KMT2A | |
| SCHEMBL6829966 | 1.00 | ALDH1A1 (0.57) | ALDH1A1TSHRHSD17B10TDP1KMT2A | |
| SCHEMBL6832061 | 1.00 | ALDH1A1 (0.57) | ALDH1A1TSHRHSD17B10TDP1KMT2A | |
| SCHEMBL8714314 | 0.98 | ALDH1A1 (0.55) | ALDH1A1TSHRHSD17B10TDP1KMT2A | |
| Hydrochloric Acid SCHEMBL942861 | 0.98 | ALDH1A1 (0.55) | ALDH1A1TSHRHSD17B10TDP1KMT2A | |
| Water SCHEMBL1506684 | 0.98 | ALDH1A1 (0.55) | ALDH1A1TSHRHSD17B10TDP1KMT2A | |
| SCHEMBL6915108 | 0.98 | ALDH1A1 (0.55) | ALDH1A1TSHRHSD17B10TDP1KMT2A | |
| SCHEMBL6832056 | 0.98 | ALDH1A1 (0.55) | ALDH1A1TSHRHSD17B10TDP1KMT2A | |
| SCHEMBL6913379 | 0.98 | ALDH1A1 (0.55) | ALDH1A1TSHRHSD17B10TDP1KMT2A | |
| SCHEMBL6917010 | 0.98 | ALDH1A1 (0.55) | ALDH1A1TSHRHSD17B10TDP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1650 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122073237-A | All-vanadium redox flow battery electrolyte and application thereof | 中国科学院大连化学物理研究所 | 2026-05-22 | — | — | CN | claimed |
| CN-122011246-A | Polyvinyl butyral resin and preparation method and application thereof | 亿光年高分子材料(江苏)有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260092135-A1 | POLYMER ELECTROLYTE COMPRISING A POLYACRYLAMIDE AND METHODS FOR THE PRODUCTION THEREOF | UMICORE NV (BE) | 2026-04-02 | — | — | US | claimed |
| US-20260094823-A1 | COMPOSITE CATHODE COMPRISING A POLYMER ELECTROLYTE AND NICKEL BASED CATHODE ACTIVE MATERIAL | UMICORE NV (BE) | 2026-04-02 | — | — | US | claimed |
| US-20260088336-A1 | ELECTROCHEMICAL CELL COMPRISING A POLYMER ELECTROLYTE AND A NICKEL BASED CATHODE ACTIVE MATERIAL | UMICORE NV (BE) | 2026-03-26 | — | — | US | claimed |
| US-20260088348-A1 | POLYMER ELECTROLYTE COMPRISING A POLYACRYLAMIDE AND METHODS FOR THE PRODUCTION THEREOF | UMICORE NV (BE) | 2026-03-26 | — | — | US | claimed |
| US-20260088289-A1 | ELECTROCHEMICAL CELL COMPRISING A POLYMER ELECTROLYTE AND A NICKEL-BASED CATHODE ACTIVE MATERIAL | UMICORE NV (BE) | 2026-03-26 | — | — | US | claimed |
| US-20260000592-A1 | TREATMENT COMPOSITIONS WITH ESTERAMINES OR SALTS THEREOF | PROCTER & GAMBLE (US) | 2026-01-01 | — | — | US | claimed |
| EP-4591370-A1 | COMPOSITE CATHODE COMPRISING A POLYMER ELECTROLYTE AND NICKEL BASED CATHODE ACTIVE MATERIAL | Umicore (BE) | 2025-07-30 | — | — | EP | claimed |
| EP-4591384-A1 | POLYMER ELECTROLYTE COMPRISING A POLYACRYLAMIDE AND METHODS FOR THE PRODUCTION THEREOF | Umicore (BE) | 2025-07-30 | — | — | EP | claimed |
| EP-0641756-A1 | Method of preparing unsaturated dimers of alpha-methylstyrenes | GOI CHEMICAL COMPANY, LTD. (JP) | 1995-03-08 | — | — | EP | claimed |
| EP-0525073-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. | DU PONT (US) | 1993-02-03 | — | — | EP | claimed |
| EP-0252875-B1 | MICROBICIDAL AGENT | CIBA-GEIGY AG (CH) | 1993-01-27 | — | — | EP | claimed |
| EP-0497976-A1 | METHOD OF PRODUCING ACETALS | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 1992-08-12 | — | — | EP | claimed |
| US-4985510-A | ADDING ACID, CROSSLINKING, HEAT TREATMENT | BRIDGESTONE CORPORATION (JP) | 1991-01-15 | — | — | US | claimed |
| US-4804568-A | POLYPYRROLE CONTAINING AROMATIC ANIONS | RICOH COMPANY, LTD. (JP) | 1989-02-14 | — | — | US | claimed |
| EP-0050325-B1 | PROCESS FOR THE PREPARATION OF INTERMEDIATES IN THE SYNTHESIS OF VITAMIN-D3 METABOLITES, AND INTERMEDIATES | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1985-07-17 | — | — | EP | claimed |
| EP-0044932-B1 | OPTIONALLY N-SUBSTITUTED AMINO-DEOXY-1,4;3,6-DIANHYDRO-HEXITE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR APPLICATION | Dr. Willmar Schwabe GmbH & Co. (DE) | 1985-04-03 | — | — | EP | claimed |
| EP-0011460-B1 | PEROXYGEN BLEACHING AND COMPOSITIONS THEREFOR | FMC Corporation (US) | 1982-09-29 | — | — | EP | claimed |
| US-4171459-A | Manufacture of α-naphthol | BASF AKTIENGESELLSCHAFT (DE) | 1979-10-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260094823-A1 | COMPOSITE CATHODE COMPRISING A POLYMER ELECTROLYTE AND NICKEL BASED CATHODE ACTIVE MATERIAL | NES, HCN2, HCN1 | ALDH1A1 1013/4885TSHR 4272/4885HSD17B10 2996/4885 |
| US-20260092135-A1 | POLYMER ELECTROLYTE COMPRISING A POLYACRYLAMIDE AND METHODS FOR THE PRODUCTION THEREOF | RPL6, EFNA1, HCN1 | ALDH1A1 2293/4885TSHR 4139/4885HSD17B10 3610/4885 |
| US-20260088336-A1 | ELECTROCHEMICAL CELL COMPRISING A POLYMER ELECTROLYTE AND A NICKEL BASED CATHODE ACTIVE MATERIAL | NES, HCN2, CDH1 | ALDH1A1 2448/4885TSHR 4452/4885HSD17B10 2155/4885 |
| US-20260000592-A1 | TREATMENT COMPOSITIONS WITH ESTERAMINES OR SALTS THEREOF | ARGLU1, DAO, PNISR | ALDH1A1 4253/4885TSHR 1360/4885HSD17B10 1629/4885 |
| US-20260088348-A1 | POLYMER ELECTROLYTE COMPRISING A POLYACRYLAMIDE AND METHODS FOR THE PRODUCTION THEREOF | HCN1, GJA1, HCN2 | ALDH1A1 635/4885TSHR 3625/4885HSD17B10 1581/4885 |
| US-20260088289-A1 | ELECTROCHEMICAL CELL COMPRISING A POLYMER ELECTROLYTE AND A NICKEL-BASED CATHODE ACTIVE MATERIAL | NES, CDH1, EMC1 | ALDH1A1 3359/4885TSHR 4227/4885HSD17B10 3063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.